{"SPADE_UN_10941": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2002/0137896 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2002_0137896_A1", "Patent Type": "Patent Application", "Publication Date": "2008-1-1", "Family Info": "US6291648,US6762296", "Patent Title": "Antitumor protein and gene encoding same.", "Abstract": "An objective of the present invention is to provide an antitumor protein and a gene encoding the same. The specification discloses a protein comprising (a) an amino acid sequence of SEQ ID No.1 or (b) a modified amino acid sequence of SEQ ID No.1 which have antitumor activity wherein one or more amino acids are added and/or inserted into the amino acid sequence of SEQ ID No.1 and/or one or more amino acids in the amino acid sequence of SEQ ID No.1 are substituted and/or deleted."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10941", "Sequence": "ETLQQTLDASRGVTTLPLGVERRTDNPIYVTWTGADTVLGDVPKSPRFALVTETRVTK", "Sequence Length": 58, "Peptide Name": "Sequence 9 from Patent US 20020137896", "Source": "Synthetic construct", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "TVL", "Absent Amino Acids": "CHMOU", "Basic Residues": 7, "Acidic Residues": 7, "Hydrophobic Residues": 24, "Polar Residues": 34, "Positive Residues": 7, "Negative Residues": 7, "Mass": 6372.12, "PI": 6.42, "Net Charge": 0, "Hydrophobicity": -0.34, "Similar Sequences": []}}}